Tag: Cyclacel Pharmaceuticals
Cyclacel’s blood cancer drug for elderly patients, sapacitabine fails in phase 3 trial
The blood cancer drug for elderly patients, sapacitabine (CYC682) developed by New Jersey based Cyclacel Pharmaceuticals has failed to meet its objective in a crucial ... Read More